| Date | Form | Description | Docs | XBRL | Pages |
| 09/11/07 | NT 10-Q | Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB |
|
3 | |
| 06/11/07 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
29 | |
| 03/12/07 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
24 | |
| 09/11/06 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
30 | |
| 06/09/06 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
27 | |
| 03/10/06 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
28 | |
| 09/09/05 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
25 | |
| 06/09/05 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
22 | |
| 03/10/05 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
24 | |
| 09/02/04 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
28 |
Latest News & Events
Anixa Biosciences and OntoChem Enter Next Stage of Development for Covid-19 Therapeutic
Read More...Anixa Biosciences Increases Previously Announced Bought Deal Offering of Common Stock to $22.5 Million
Read More...Anixa Biosciences Announces $10 Million Bought Deal Offering of Common Stock
Read More...